The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Washington University experience with FOLFIRINOX in pancreatic cancer.
Parvin F. Peddi
No relevant relationships to disclose
Benjamin R. Tan
No relevant relationships to disclose
Joel Picus
No relevant relationships to disclose
Steven Sorscher
No relevant relationships to disclose
Rama Suresh
No relevant relationships to disclose
Albert C. Lockhart
No relevant relationships to disclose
Christine Menias
No relevant relationships to disclose
David Linehan
No relevant relationships to disclose
Andrea Wang-Gillam
No relevant relationships to disclose